New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

by Emma Beckett,The ConversationCredit: Markus Winkler from PexelsMany havedeclareddrugs like Ozempic could "end obesity" by reducing the appetite and waistlines of million
Breakthroughs April 28,2024
Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

Drugs like Ozempic won't 'cure' obesity but they might make us more fat-phobic

by Emma Beckett,The ConversationCredit: Markus Winkler from PexelsMany havedeclareddrugs like Ozempic could "end obesity" by reducing the appetite and waistlines of million
Breakthroughs April 28,2024
Plozasiran reduces triglyceride levels by 74% at 24 weeks

Plozasiran reduces triglyceride levels by 74% at 24 weeks

byAmerican College of CardiologyCredit: CC0 Public DomainIn patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran red
Breakthroughs April 28,2024
Plozasiran reduces triglyceride levels by 74% at 24 weeks

Plozasiran reduces triglyceride levels by 74% at 24 weeks

byAmerican College of CardiologyCredit: CC0 Public DomainIn patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran red
Breakthroughs April 28,2024
Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe
Breakthroughs April 28,2024
Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe
Breakthroughs April 28,2024
Follow-up finds landmark steroid study remains safe 50 years on

Follow-up finds landmark steroid study remains safe 50 years on

byUniversity of AucklandCredit: Bruno Abdiel from PexelsA study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given c
Breakthroughs April 28,2024
Follow-up finds landmark steroid study remains safe 50 years on

Follow-up finds landmark steroid study remains safe 50 years on

byUniversity of AucklandCredit: Bruno Abdiel from PexelsA study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given c
Breakthroughs April 28,2024
AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur
Oncology April 28,2024
AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur
Oncology April 28,2024
Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha
Neurology April 28,2024
Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha
Neurology April 28,2024
Preoperative GLP-1 agonist use does not increase aspiration

Preoperative GLP-1 agonist use does not increase aspiration

by Elana GotkinePreoperative glucagon-like peptide-1 (GLP-1) agonist use does not increase the risk for aspiration or subsequent pneumonia in patients undergoing various surgical procedures, according
Breakthroughs April 28,2024
Preoperative GLP-1 agonist use does not increase aspiration

Preoperative GLP-1 agonist use does not increase aspiration

by Elana GotkinePreoperative glucagon-like peptide-1 (GLP-1) agonist use does not increase the risk for aspiration or subsequent pneumonia in patients undergoing various surgical procedures, according
Breakthroughs April 28,2024
Call to reduce repeat 'within-episode' antibiotic prescriptions for respiratory tract infections in primary care

Call to reduce repeat 'within-episode' antibiotic prescriptions for respiratory tract infections in primary care

byUniversity of BristolCredit: Unsplash/CC0 Public DomainA new study exploring the use of repeat antibiotic prescriptions for the same respiratory tract infection (RTI) episode—known as repeat &
Breakthroughs April 28,2024
Call to reduce repeat 'within-episode' antibiotic prescriptions for respiratory tract infections in primary care

Call to reduce repeat 'within-episode' antibiotic prescriptions for respiratory tract infections in primary care

byUniversity of BristolCredit: Unsplash/CC0 Public DomainA new study exploring the use of repeat antibiotic prescriptions for the same respiratory tract infection (RTI) episode—known as repeat &
Breakthroughs April 28,2024
Study supports use of cystic fibrosis drug in infants from four weeks of age

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i
Breakthroughs April 28,2024
Study supports use of cystic fibrosis drug in infants from four weeks of age

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i
Breakthroughs April 28,2024
Lies about birth control are propagating on social media—here are the facts

Lies about birth control are propagating on social media—here are the facts

by Christopher O'Sullivan,The ConversationCredit: CC0 Public DomainSocial media is full of bad advice when it comes to your health. With so much of this content created by influencers who do
Breakthroughs April 28,2024
Lies about birth control are propagating on social media—here are the facts

Lies about birth control are propagating on social media—here are the facts

by Christopher O'Sullivan,The ConversationCredit: CC0 Public DomainSocial media is full of bad advice when it comes to your health. With so much of this content created by influencers who do
Breakthroughs April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com